Security Notice: Please be aware of impersonation attempts using our company name
Legitimate communications from Ascent Research will only come from official @ascentresearch.com email addresses.
Quick Order Cart

Cat. No. ARG33154

BLOC1S3 Knockout HT29 Polyclonal Cells

  • Product Type:

    Polyclonal Cell Population

  • Species:

    Homo sapiens (Human)

BLOC1S3 Knockout HT29 Polyclonal Cells provide a CRISPR/Cas9-edited polyclonal knockout population of the BLOC1S3 gene in the human colorectal adenocarcinoma HT29 cell line, a widely used intestinal epithelial model. BLOC1S3 encodes the BLOS3 subunit of the BLOC-1 complex, which regulates endosomal trafficking of melanogenic enzymes, ATP7A, and LAMP1 via interactions with Rab32/Rab38 and AP-3. This knockout model enables studies of lysosome-related organelle biogenesis defects in colorectal cancer, including effects on migration and invasion, and serves as a tool for Hermansky-Pudlak syndrome research. Applications include immunofluorescence, flow cytometry, and transwell assays to dissect BLOC-1-dependent trafficking.

Inquire Now

In stock

Ships next business day


Ask a Question

Shipping Info:

Cryopreserved in vials and shipped on dry ice


Disclaimer:

For Research Use Only

  • Characteristics

    Host Cell

    HT29

    Gene Name

    BLOC1S3

    Gene Identifier

    NCBI Gene ID 388552

    Storage

    Liquid nitrogen (LN2)

  • Culture Conditions

    Growth medium

    McCoy's 5A

    Supplement(s)

    10% Fetal Bovine Serum, 1% Penicillin-Streptomycin Solution

    Temperature

    37°C

    Atmosphere

    5% CO₂

  • Quality Control

    Sterility testing

    The bacterial, yeast, and fungi are not detected in these cells by daily monitor.

    Mycoplasma testing

    Negative for mycoplasma through PCR analysis

  • Disclaimer

    Intended Use

    This product is intended for laboratory in vitro use only. lt is not intended for diagnostic, therapeutic, or clinical applications.

    Disclaimer

    Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability. References to scientific literature and patents are for informational purposes only, and the customer assumes sole responsibility for verifying their accuracy.

    By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use, including compliance with all applicable safety and environmental regulations and precautions. Relevant laws, regulations, and ethical guidelines must be followed in conducting any research, modifications, or derivatives derived from this product.

    This product is provided "AS IS", and except as expressly stated herein, Ascent Research disclaims all other warranties, express or implied. Under no circumstances shall Ascent Research, its affiliates, or representatives be liable for indirect, incidental, consequential, or punitive damages arising from the use of this material. While Ascent Research employs rigorous quality control measures, we shall not be held responsible for damages resulting from misidentification or misinterpretation of the provided materials.

Description

The BLOC1S3 Knockout HT29 Polyclonal Cells product offers a CRISPR/Cas9-edited polyclonal knockout cell population for functional studies of the BLOC1S3 gene. Derived from HT29 human colorectal adenocarcinoma cells, this heterogeneous pool provides a robust loss-of-function model without clonal selection biases, suitable for investigating BLOC1S3-dependent processes in an epithelial context.

HT29 cells, isolated from a female patient, serve as a well-established intestinal epithelial model. These adherent cells recapitulate enterocyte-like polarity and are widely used in colorectal cancer research to study tumorigenesis, migration, and drug responses, making them an appropriate host for probing endosomal trafficking pathways relevant to both normal and malignant intestinal biology.

BLOC1S3 encodes BLOS3, a core subunit of the BLOC-1 complex essential for biogenesis of lysosome-related organelles. BLOC-1 functions downstream of the retromer VPS26/VPS35/SNX6 and small GTPases Rab32/Rab38, regulated by ANKRD27/Varp, and interacts with AP-3, BLOC-2, and SNARE proteins syntaxin 13 and VAMP7. Disruption of BLOC1S3 impairs trafficking of melanogenic enzymes TYR, TYRP1, DCT, the copper transporter ATP7A, and lysosomal membrane proteins LAMP1 and CD63 to specialized organelles, while general endocytosis remains largely unaffected.

In HT29 colorectal cancer cells, BLOC1S3 knockout provides a unique model to dissect how defects in lysosome-related organelle biogenesis intersect with epithelial tumor biology. Because mutations in BLOC1S3 cause Hermansky-Pudlak syndrome type 8, this polyclonal knockout tool enables investigation of the epithelial manifestations of this disorder and the potential contribution of trafficking defects to colorectal cancer cell proliferation, migration, and invasion.

Typical applications include western blotting and RT-qPCR for knockout validation, immunofluorescence for mislocalized LAMP1 and TYR, flow cytometry for CD63 surface expression, and functional assays such as transwell migration and MTT viability. The cells also support ultrastructural analysis by electron microscopy and studies of BLOC-1 complex function in tumorigenesis and endosomal sorting in intestinal epithelia. For technical inquiries, contact Ascent Research.

Reset Password

    Reach Us Questions? Click Me Here!

    Fill out the form below and a member of our team will contact you shortly!

    *Required field



      Reach Us

      Fill out the form below and a member of our team will contact you shortly!

      *Required field

      Product Inquiry (Optional)